Superseded Protocol Documents

The documents below are protocol documents that are now superseded. These documents may not have been submitted for approval in all regions. For current protocol documents please click here.


REMAP-CAP Core Protocol

Core Protocol - Version 1

Core Protocol - Version 1.1

Core Protocol - Version 2

Core Protocol - Version 2.1

Pandemic Appendix to the Core Protocol

Pandemic Appendix - Version 1

Pandemic Appendix - Version 1.1

Antibiotic Domain-Specific Appendix

Antibiotic DSA - Version 1

Antibiotic DSA - Version 1.1

Antibiotic DSA - Version 2

Macrolide Duration Domain-Specific Appendix

Macrolide DSA - Version 1

Macrolide DSA -Version 1.1

Macrolide DSA - Version 2

Corticosteroid Domain-Specific Appendix

Corticosteroid DSA - Version 1

Corticosteroid DSA - Version 1.1

Corticosteroid DSA - Version 2

Corticosteroid DSA - Version 3

Corticosteroid DSA - Version 3.1

Corticosteroid DSA - Version 3.2

COVID-19 Antiviral Domain-Specific Appendix

COVID-19 Antiviral DSA - Version 1

COVID-19 Antiviral DSA - Version 2

COVID-19 Antiviral DSA - Version 2.1

COVID-19 Immune Modulation Domain-Specific Appendix

COVID-19 Immune Modulation DSA - Version 1

COVID-19 Immune Modulation DSA - Version 2

Immunoglobulin Domain-Specific Appendix

Immunoglobulin DSA - Version 1

Immunoglobulin DSA - Version 1.01

Immunoglobulin DSA - Version 2.2 (Canada)

Immunoglobulin DSA - Version 2.3 (USA)

Immunoglobulin DSA - Version 2.4 (Australia)

Immunoglobulin DSA - Version 2.5 (New Zealand)

Anticoagulation Domain-Specific Appendix

Anticoagulation DSA - Version 1

Anticoagulation DSA - Version 2

Vitamin C Domain-Specific Appendix

Vitamin C DSA - Version 1

Simvastatin Domain-Specific Appendix

Simvastatin DSA - Version 1

Simvastatin DSA - Version 1.1

Antiplatelet Domain-Specific Appendix

Antiplatelet DSA - Version 1

ACE2 RAS Domain-Specific Appendix

ACE2 RAS DSA - V1

ACE2 RAS DSA - V2